跳至主要内容
临床试验/EUCTR2014-004013-85-DE
EUCTR2014-004013-85-DE进行中(未招募)1 期

Sequential versus simultaneous vaccination with pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPV23) in unvaccinated older adults: Immunological memory and antibody levels - SimVac

Friedrich Schiller University Jena0 个研究点目标入组 132 人开始时间: 2015年11月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
132

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • male and female adults aged 60 years
  • written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 132

排除标准

  • Hypersensitivity to any component of the vaccine
  • prior pneumococcal vaccination
  • Pneumonia in the last 2 months
  • active infection
  • autoimmune disorder (e.g. lupus erythematodes,Wegener's granulomatosis)
  • ongoing or planned immunosuppressive therapy (with corticosteroid therapy from a prednisolone equivalent dose = 5 mg /d)
  • active tumor disease
  • drug or alcohol abuse, or estimate other diseases that do not allow the person concerned, the nature and scope and possible consequences of the trial, incl. non-cooperation
  • expectancy of life < 2 years
  • receive blood products in the last six month
  • all states which represent a contraindication to intramuscular administration of vaccines
  • blood coagulation disorders (e.g. haemophilia, use of oral anticoagulation ,current thrombolytic therapy )
  • incineration, injury or infection at the planned injection position
  • Plegie or paresis of the extremities at the planned injection position
  • states of shock
  • parallel participation in another clinical trial with intervention

研究者

发起方
Friedrich Schiller University Jena

相似试验